Qi Qi, Peng Jian, Liu Wei, You Qidong, Yang Yong, Lu Na, Wang Guangji, Guo Qinglong
Jiangsu Key Laboratory of Carcinogenesis and Intervention (China Pharmaceutical University), 24 Tong Jia Xiang, Nanjing, Jiangsu 210009, People's Republic of China.
Phytother Res. 2009 Mar;23(3):417-22. doi: 10.1002/ptr.2645.
Wogonin, one active ingredient extract from the radix of Scutellaria baicalensis Georgi, is known to possess a broad spectrum of pharmacological, medicinal and therapeutic properties, especially the anticancer activity studied recently. However, no extensive safety studies have been conducted to date. In this paper, the acute and sub-chronic toxicity of the agent were determined using albino mice and Sprague-Dawley rats as animal models. Histopathological examination and viscera parameter investigation were also carried out after autopsy. The LD(50) of wogonin administered by the intravenous injection was 286.15 mg/kg and the 95% confidence limit was 278.27-295.26 mg/kg. A long period of treatment with a high dose of wogonin (120 mg/kg) could induce heart injury in rats. These results provide a foundation for the further clinical investigation of this promising anticancer agent.
汉黄芩素是从黄芩根中提取的一种活性成分,已知具有广泛的药理、药用和治疗特性,尤其是最近研究的抗癌活性。然而,迄今为止尚未进行广泛的安全性研究。本文以白化小鼠和Sprague-Dawley大鼠为动物模型,测定了该药物的急性和亚慢性毒性。尸检后还进行了组织病理学检查和内脏参数调查。静脉注射汉黄芩素的半数致死量(LD50)为286.15mg/kg,95%置信限为278.27-295.26mg/kg。高剂量(120mg/kg)的汉黄芩素长期治疗可导致大鼠心脏损伤。这些结果为进一步临床研究这种有前景的抗癌药物奠定了基础。